Immunotherapy-reversed compulsive, monoaminergic, circadian rhythm disorder in morvan syndrome

Neurology

Volumn 71, Issue 24, 2008, Pages 2008-2010

  Spinazzi, M ^a,c   Argentiero, V ^a   Zuliani, L ^a   Palmieri, A ^a   Tavolato, B ^a   Vincent, A ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c Clinica Neurologica II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AZATHIOPRINE; CLONIDINE; CREATINE KINASE; CYCLOPHOSPHAMIDE; FLUORODEOXYGLUCOSE F 18; MELATONIN; METHYLPREDNISOLONE; PREDNISONE; PROLACTIN; BIOGENIC AMINE; CATECHOLAMINE; IMMUNOSUPPRESSIVE AGENT; SEROTONIN; VOLTAGE GATED POTASSIUM CHANNEL;

AGED; ARTICLE; BRAIN DISEASE; CASE REPORT; CIRCADIAN RHYTHM SLEEP DISORDER; CLINICAL EXAMINATION; COMPULSION; CREATINE KINASE BLOOD LEVEL; DISEASE COURSE; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAM; ELECTROMYOGRAM; ELECTRON MICROSCOPY; ERYTHROCYTE SEDIMENTATION RATE; GRAND MAL EPILEPSY; HUMAN; HYPOMANIA; HYPONATREMIA; IMMUNOTHERAPY; INSOMNIA; IRRITABILITY; LEG PAIN; MALE; MONOAMINERGIC SYSTEM; MORVAN SYNDROME; MUSCLE BIOPSY; MUSCLE CRAMP; NEUROLOGIC DISEASE; NEUROMUSCULAR DISEASE; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMAPHERESIS; POLYSOMNOGRAPHY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; RESPIRATORY FAILURE; SENSORY DYSFUNCTION; TEMPORAL LOBE EPILEPSY; TREATMENT OUTCOME; BASAL GANGLION; DRUG EFFECT; ENDOCRINE DISEASE; EPILEPSY; EXTRAPYRAMIDAL SYNDROME; GENETICS; IMMUNOLOGY; METABOLISM; METHODOLOGY; MIDDLE AGED; MYOKYMIA; PATHOPHYSIOLOGY; SECRETION; SLEEP DISORDER;

AZATHIOPRINE; BASAL GANGLIA; BASAL GANGLIA DISEASES; BIOGENIC MONOAMINES; CATECHOLAMINES; CHRONOBIOLOGY DISORDERS; COMPULSIVE BEHAVIOR; CYCLOPHOSPHAMIDE; ENDOCRINE SYSTEM DISEASES; EPILEPSY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; IMMUNOTHERAPY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOKYMIA; PLASMAPHERESIS; POSITRON-EMISSION TOMOGRAPHY; POTASSIUM CHANNELS, VOLTAGE-GATED; SEROTONIN; TREATMENT OUTCOME;

EID: 58149383554     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/01.wnl.0000336972.62597.41     Document Type: Article

References (6)

1. Vincent A, Lang B, Kleopa KA. Autoimmune channelopathies and related neurological disorders. Neuron 2006;52: 123-138.
2. Liguori R, Vincent A, Clover L, et al. Morvan's syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels. Brain 2001;124:2417-2426.
3. Eadie MJ. Convulsive ergotism: epidemics of the serotonin syndrome? Lancet Neurol 2003;2:429-434.
4. Cortelli P, Pierangeli G, Provini F, Plazzi G, Lugaresi E. Blood pressure rhythms in sleep disorders and dysautonomia. Ann NY Acad Sci 1996;783:204-221.
5. Epstein J, Stern E, Silbersweig D. Mesolimbic activity associated with psychosis in schizophrenia. Symptomspecific PET studies. Ann NY Acad Sci 1999;877:562-574.
6. Saxena S, Brody AL, Schwartz JM, Baxter LR. Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder. Br J Psychiatry Suppl 1998;35: 26-37.